Peptides and Non Peptides of Oncologic and Neuroendocrine Relevance, Softcover reprint of the original 1st ed. 2003 From Basic to Clinical Research
Auteur : Müller E.E.
Describes the ability of a series of endocrine-derived compounds, i.e. CHRH, LHRH, somatostatin, anti-androgens, and aromatase inhibitors to exert a direct anti-neoplastic activity or to potentiate the activity of traditional chemotherapeutic agents on neuroendocrine and solid tumors. In addition, a new class of potent GH-releasers, GSHs/Ghrelin, endowed with important endocrine and extra-endcocrine action, is presented. Therefore, in addition to traditional chemotherapy, characterized by high toxicity and non-selective action on tumoral cells, the reader can find a new approach with more selective, less cytotoxic endocrine derived compounds.
Describes a new approach to tumor therapy based on more selective, less cytotoxic endocrine derived compounds
Date de parution : 10-2012
Ouvrage de 197 p.
15.5x23.5 cm
Disponible chez l'éditeur (délai d'approvisionnement : 15 jours).
Prix indicatif 158,24 €
Ajouter au panierDate de parution : 09-2003
Ouvrage de 197 p.
15.5x23.5 cm